Cubist Systematic Strategies, LLC Ampio Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.16 - $0.47 $2,859 - $8,399	17,872 New	17,872 $3,000
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.8 $45,186 - $67,219	-37,344 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.56 - $1.98 $231,869 - $294,295	-148,634 Reduced 79.92%	37,344 $62,000
Q1 2021 May 17, 2021	BUY	$1.36 - $2.49 $234,434 - $429,221	172,378 Added 1267.49%	185,978 $314,000
Q4 2020 Feb 16, 2021	BUY	$0.75 - $2.76 $10,200 - $37,536	13,600 New	13,600 $22,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.